Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis
Clinical trial NCT06880276 · RECRUITING
Trial details
- NCT number
- NCT06880276
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-16
- Primary completion
- 2027-03-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.